Assessing the performance of two dry powder inhalers in preschool children using an idealized pediatric upper airway model

International Journal of Pharmaceutics

Volumn 444, Issue 1-2, 2013, Pages 169-174

  Below, Antje ^a   Bickmann, Deborah ^b   Breitkreutz, Joerg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Children; Dry powder inhaler; Easyhaler; Idealized throat model; Novolizer; Pediatric upper airway model

Indexed keywords

BECLOMETASONE DIPROPIONATE; EASYHALER; SALBU NOVOLIZER; SALBUHEXAL; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; DRUG FORMULATION; FLOW RATE; GEOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; PEAK INSPIRATORY FLOW; POWDER INHALER; PRESCHOOL CHILD; PRIORITY JOURNAL; REPRODUCIBILITY; STEADY STATE; UPPER RESPIRATORY TRACT;

CHILD, PRESCHOOL; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; HUMANS; MALE; MODELS, ANATOMIC; RESPIRATORY SYSTEM;

EID: 84874321222     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.007     Document Type: Article

References (33)

1. G.M. Allen, B.P. Shortall, T. Gemci, T.E. Corcoran, and N.A. Chigier Computational simulations of airflow in an in vitro model of the pediatric upper airways J. Biomech. Eng. Trans. ASME 126 2004 604 613
2. I. Amirav, M.T. Newhouse, and Y. Mansour Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma Pediatr. Pulmonol. 39 2005 447 451
3. W.D. Bennett, and K.L. Zeman Effect of body size on breathing pattern and fine-particle deposition in children J. Appl. Physiol. 97 2004 821 826
4. Bickmann, D.; 2008. Examining inhaler performance using a child's throat model. In: RDD Conference, Arizona.
5. H. Bisgaard, and S. Szefler Prevalence of asthma-like symptoms in young children Pediatr. Pulmonol. 42 2007 723 728
6. Y.S. Cheng, S.M. Smith, H.C. Yeh, D.B. Kim, K.H. Cheng, and D.L. Swift Deposition of ultrafine aerosols and thoron progency in replicas of nasal airways o young-children Aerosol Sci. Technol. 23 1995 541 552
7. Y.S. Cheng, Y. Yamada, H.C. Yeh, and D.L. Swift Deposition of ultrafine aerosols in a human oral cast Aerosol Sci. Technol. 12 1990 1075 1081
8. T.S. Cohen, and A. Prince Cystic fibrosis: a mucosal immunodeficiency syndrome Nat. Med. 18 2012 509 519
9. T.E. Corcoran, B.P. Shortall, I.K. Kim, M.P. Meza, and N. Chigier Aerosol drug delivery using heliox and nebulizer reservoirs: results from an MRI-based pediatric model J. Aerosol Med. 16 2003 263 271
10. A.H. DeBoer, P. Hagedoorn, D. Gjaltema, J. Goedes, and H.W. Frijlink Air classifier technology (ACT) in dry powder inhalation. Part 3. Design and development of an air classifier family for the Novolizer® multi-dose dry powder inhaler Int. J. Pharm. 310 2006 72 80
11. W.H. DeHaan, and W.H. Finlay Predicting extrathoracic deposition from dry powder inhalers J. Aerosol Sci. 35 2004 309 331
12. T. Ehtezazi, M.A. Horsfield, P.W. Barry, P. Goodenough, and C. O'Callaghan Effect of device inhalational resistance on the three-dimensional configuration of the upper airway J. Pharm. Sci. 94 2005 1418 1426
13. T. Ehtezazi, K.W. Southern, D. Allanson, I. Jenkinson, and C. O'Callaghan Suitability of the upper airway models obtained from MRI studies in simulating drug lung deposition from inhalers Pharm. Res. 22 2005 166 170
14. European Pharmacopoiea 7.0.
15. L. Golshahi, and W.H. Finlay An idealized child throat that mimics average pediatric oropharyngeal deposition Aerosol Sci. Technol. 46 2012 I IV
16. B. Grgic, W.H. Finlay, P.K.P. Burnell, and A.F. Heenan In vitro intersubject and intrasubject deposition measurements in realistic mouth-throat geometries J. Aerosol Sci. 35 2004 1025 1040
17. K.K. Isaacs, and T.B. Martonen Particle deposition in children's lungs: theory and experiment J. Aerosol Med. 18 2005 337 353
18. H.M. Janssens, J.C. De Jongste, W.J. Fokkens, S.G.F. Robben, K. Wouters, and H. Tiddens The Sophia Anatomical Infant Nose-Throat (SAINT) model: a valuable tool to study aerosol deposition in infants J. Aerosol Med. 14 2001 433 441
19. D. Kohler The Novolizer®: overcoming inherent problems of dry powder inhalers Respir. Med. 98 2004 S17 S21
20. K. Malmstrom, R. Sorva, and M. Silvasti Application and efficacy of the multi-dose powder inhaler, Easyhaler®, in children with asthma Pediatr Allergy Immunol. 10 1999 66 70
21. S. Minocchieri, J.M. Burren, M.A. Bachmann, G. Stern, J. Wildhaber, S. Buob, R. Schindel, R. Kraemer, U.P. Frey, and M. Nelle Development of the premature infant nose throat-model (PrINT-Model)-an upper airway replica of a premature neonate for the study of aerosol delivery Pediatr. Res. 64 2008 141 146
22. Mitchell, J.P.; Nagel, M.; Finlay, B.; 2011. Advances in models for laboratory testing of inhalers: There's more to it than meets the nose or mouth - The ADAM face models. In: RDD Conference, Berlin.
23. U. Munzel, K. Marschall, B. Fyrnys, and M. Wedel Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers Curr. Med. Res. Opin. 21 2005 827 833
24. S.P. Newman, and H.K. Chan In vitro/in vivo comparisons in pulmonary drug delivery J. Aerosol Med. Pulm. Drug Deliv. 21 2008 77 84
25. B. Olsson Aerosol-particle generation from dry powder inhalers-can the equal pressurized metered dose inhaler J. Aerosol Med. 8 1995 S13 S19
26. M. Rosenfeld, R.L. Gibson, S. McNamara, J. Emerson, J.L. Burns, R. Castile, P. Hiatt, K. McCoy, C.B. Wilson, A. Inglis, A. Smith, T.R. Martin, and B.W. Ramsey Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis Pediatr. Pulmonol. 32 2001 356 366
27. K.G. Schuepp, J. Jauernig, H.M. Janssens, H. Tiddens, D.A. Straub, R. Stangl, M. Keller, and J.H. Wildhaber In vitro determination of the optimal particle size for nebulized aerosol delivery to infants J. Aerosol Med. 18 2005 225 235
28. K.W. Stapleton, E. Guentsch, M.K. Hoskinson, and W.H. Finlay On the suitability of k-epsilon turbulence modeling for aerosol deposition in the mouth and throat: a comparison with experiment J. Aerosol Sci. 31 2000 739 749
29. J. Storey-Bishoff, M. Noga, and W.H. Finlay Deposition of micrometer-sized aerosol particles in infant nasal airway replicas J. Aerosol Sci. 39 2008 1055 1065
30. C. Vogelberg, H.J. Kremer, B. Ellers-Lenz, M. Engel, J. Maus, F. Conrad, and R. Hermann Clinical evaluation of the peak inspiratory flow generated by asthmatic children through the Novolizer® Respir. Med. 98 2004 924 931
31. A. von Berg, H.J. Kremer, B. Ellers-Lenz, F. Conrad, K. Erb, J. Maus, and R. Hermann Peak inspiratory flow rates generated through the Novolizer® and the Turbuhaler® dry powder inhaler devices by children with stable asthma J. Aerosol Med. 20 2007 50 58
32. H. Wachtel Can pediatric throat models and air flow profiles improve our dose finding strategy? RDD Conference Orlando 2010
33. Walsh, J. Bickmann, D. Breitkreutz, J. Chariot-Goulet, and M. EuPfi Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments Int. J. Pharm. 415 2011 221 231